RAS Wild Type

topic on 1 show · 1 statements across 1 episodes

the a16z Podcast

1 statements about RAS Wild Type, every show

a16z Disclosure
Lim admits skepticism on targeting wild-type RAS until RevMed proved it
“Until RevMed showed that that you could target RAS wild type. I actually was very skeptical that we'd be able to do that. But then when I saw the data, I was just amazed that this was safe and reasonably well tolerated.”
Jonathan Lim Apr 30, 2025 ▶ 11:35 Biotech CEO on where we are in the fight to cure cancer

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.